Gut microbial metabolite, sphingosine-1-phosphate (S1P), drives mesangial cell phenotypic transformation and accelerates progression of IgA nephropathy via CCL2-MET-FAK pathway
Open Access
- 18 October 2025
- journal article
- Published by Elsevier in Current Research in Microbial Sciences
- Vol. 9, 100494
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82304948)
- Natural Science Foundation of Shanghai Municipality (24ZR1461700)
- Health and Family Planning Commission of Sichuan Province
- Shanghai Municipal Health Commission (202 540 104)
This publication has 39 references indexed in Scilit:
- The contribution of the sphingosine 1-phosphate signaling pathway to chronic kidney diseases: recent findings and new perspectivesPflügers Archiv - European Journal of Physiology, 2024
- C5a enhances Vδ1 T cells recruitment via the CCL2-CCR2 axis in IgA nephropathyInternational Immunopharmacology, 2023
- Alterations of gut microbiota and metabolome in early chronic kidney disease patients complicated with hyperuricemiaHeliyon, 2023
- Altered serum metabolic profile in patients with IgA nephropathyClinica Chimica Acta, 2023
- Sphingosine-1-phosphate receptor 2 plays a dual role depending on the stage of cell differentiation in renal epithelial cellsLife Sciences, 2023
- Assessing prognosis in IgA nephropathyKidney International, 2022
- Chronic treatment with the (iso-)glutaminyl cyclase inhibitor PQ529 is a novel and effective approach for glomerulonephritis in chronic kidney diseaseNaunyn-Schmiedeberg's Archives of Pharmacology, 2021
- Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese populationInternational Immunopharmacology, 2020
- The TLR4-MyD88-NF-κB pathway is involved in sIgA-mediated IgA nephropathyJournal Of Nephrology, 2020
- Molecular Insights into the Pathogenesis of IgA NephropathyTrends in Molecular Medicine, 2015